levodopa has been researched along with warfarin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Avdeef, A; Tam, KY | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Romankiewicz, JA | 1 |
| Catron, PW; Flynn, ET | 1 |
| D'Arcy, PF | 1 |
| Ando, H; Masamoto, Y; Murata, Y; Shimoishi, Y; Tada, M; Takahata, K | 1 |
| Chen, ST; Chu, YC; Huang, YC; Lyu, RK; Wu, YR | 1 |
| Choi, HS; Huang, HS; Lee, BK; Lee, CK; Lee, HJ; Lee, MK; Lim, SC; Yang, YJ | 1 |
| Arung, ET; Kondo, R; Kuspradini, H; Kusuma, IW; Shimizu, K | 1 |
| Khoshroo, A; Mazloum-Ardakani, M | 1 |
| Guerrero, MF; López, JL; Olaya, MDP; Vergel, NE; Viña, MD | 1 |
2 review(s) available for levodopa and warfarin
| Article | Year |
|---|---|
Adjuvant drug therapy for decompression sickness: a review.
Topics: Adrenal Cortex Hormones; Animals; Anti-Arrhythmia Agents; Aspirin; Bronchodilator Agents; Coumarins; Cyproheptadine; Decompression Sickness; Dextrans; Diazepam; Dipyridamole; Fluid Therapy; Heparin; Humans; Indomethacin; Levodopa; Niacin; Vasoconstrictor Agents; Vasodilator Agents | 1982 |
Herbs and drugs: a risky mix.
Topics: Anticoagulants; Antiparkinson Agents; Drug Interactions; Humans; Levodopa; Plants, Medicinal; Warfarin | 2001 |
18 other study(ies) available for levodopa and warfarin
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Effects of antacids on gastrointestinal absorption of drugs.
Topics: Animals; Antacids; Aspirin; Chlordiazepoxide; Chlorpromazine; Dicumarol; Digitoxin; Digoxin; Ephedrine; Guinea Pigs; Humans; Intestinal Absorption; Iron; Isoniazid; Levodopa; Naproxen; Pentobarbital; Pharmaceutical Preparations; Quinidine; Quinine; Rats; Sulfadiazine; Tetracyclines; Warfarin | 1976 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
Mushroom tyrosinase inhibitory activity of esculetin isolated from seeds of Euphorbia lathyris L.
Topics: Agaricales; Binding, Competitive; Coumarins; Euphorbiaceae; Inhibitory Concentration 50; Kinetics; Levodopa; Peptides; Pyrones; Seeds; Structure-Activity Relationship; Umbelliferones | 2003 |
Parkinsonism in a patient with antiphospholipid syndrome--case report and literature review.
Topics: Adult; Anticoagulants; Antiparkinson Agents; Antiphospholipid Syndrome; Brain; Cerebral Arteries; Corpus Striatum; Dementia, Vascular; Female; Humans; Intracranial Thrombosis; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinsonian Disorders; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Warfarin | 2008 |
Effects of scoparone on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Survival; Coumarins; Cyclic AMP; Cytotoxins; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Extracellular Fluid; Intracellular Fluid; Levodopa; Molecular Structure; Neurons; Neuroprotective Agents; PC12 Cells; Protein Kinases; Rats; Substantia Nigra; Tyrosine 3-Monooxygenase; Vasodilator Agents | 2009 |
Validation of Eupatorium triplinerve Vahl leaves, a skin care herb from East Kalimantan, using a melanin biosynthesis assay.
Topics: Bleaching Agents; Borneo; Cell Line, Tumor; Cell Survival; Coumarins; Eupatorium; Humans; Inhibitory Concentration 50; Levodopa; Melanins; Melanoma, Experimental; Monophenol Monooxygenase; Plant Extracts; Plant Leaves; Skin Care | 2012 |
Nano composite system based on coumarin derivative-titanium dioxide nanoparticles and ionic liquid: determination of levodopa and carbidopa in human serum and pharmaceutical formulations.
Topics: Carbidopa; Carbon; Catalysis; Chemistry, Pharmaceutical; Coumarins; Electrochemical Techniques; Electrodes; Humans; Hydrogen-Ion Concentration; Ionic Liquids; Levodopa; Metal Nanoparticles; Nanocomposites; Oxidation-Reduction; Titanium | 2013 |
Coumarin analogue 3-methyl-7H-furo[3,2-g] chromen-7-one as a possible antiparkinsonian agent
Topics: Animals; Antiparkinson Agents; Carbidopa; Catalepsy; Coumarins; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Locomotion; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Reserpine | 2019 |